Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents

Proteases that are expressed during the erythocytic stage of Plasmodium falciparum are newly explored drug targets for the treatment of malaria. We report here the discovery of potent inhibitors of PfA-M1, a metallo-aminopeptidase of the parasite. These compounds are based on a malonic hydroxamic te...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2007-03, Vol.50 (6), p.1322-1334
Hauptverfasser: Flipo, Marion, Beghyn, Terence, Leroux, Virginie, Florent, Isabelle, Deprez, Benoit P, Deprez-Poulain, Rebecca F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1334
container_issue 6
container_start_page 1322
container_title Journal of medicinal chemistry
container_volume 50
creator Flipo, Marion
Beghyn, Terence
Leroux, Virginie
Florent, Isabelle
Deprez, Benoit P
Deprez-Poulain, Rebecca F
description Proteases that are expressed during the erythocytic stage of Plasmodium falciparum are newly explored drug targets for the treatment of malaria. We report here the discovery of potent inhibitors of PfA-M1, a metallo-aminopeptidase of the parasite. These compounds are based on a malonic hydroxamic template and present a very good selectivity toward neutral aminopeptidase (APN-CD13), a related protease in mammals. Structure−activity relationships in these series are described. Further optimization of the best inhibitor yielded a nanomolar, selective inhibitor of PfA-M1. This inhibitor displays good physicochemical and pharmacokinetic properties and a promising antimalarial activity.
doi_str_mv 10.1021/jm061169b
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_mnhn_02904302v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19756461</sourcerecordid><originalsourceid>FETCH-LOGICAL-a447t-4e42a1bee607ae7878343af95a899bf5e3ccc411c54daabf07407ed0c2fb947d3</originalsourceid><addsrcrecordid>eNqF0U2P0zAQBmALgdiycOAPIF9AAingr9jJsVoBu9CFSltA4mJNnAlxSeJipxX8e7Lbqr0gcRrZ8-jVSC8hTzl7zZngb9Y905zrsrpHZjwXLFMFU_fJjDEhMqGFPCOPUlozxiQX8iE540YKrXk-I-2nsMOO3mCHbvQ7pFdD6ys_hphoaOjYIv3uB0eXHaQ-1B46Ou_9EDa4GX0NCemymWfXnEKiyzDiMN6RafTQQbx7_Jh-02PyoIEu4ZPDPCdf3r1dXVxmi8_vry7miwyUMmOmUAngFaJmBtAUppBKQlPmUJRl1eQonXOKc5erGqBqmFHMYM2caKpSmVqek1f73BY6u4nTGfGPDeDt5Xxh-6EdLBMlU5KJHZ_wiz3exPBri2m0vU8Ouw4GDNtkDRNaCqH-C3lpcq30beLLPXQxpBSxOd7Amb0tyx7LmuyzQ-i26rE-yUM7E3h-AJAcdE2Ewfl0coXORS7l5LK982nE38c9xJ9WG2lyu1re2G_Xiw9fi9VHy0-54JJdh20cpkb-ceBfKl22jg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19756461</pqid></control><display><type>article</type><title>Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents</title><source>ACS Publications</source><source>MEDLINE</source><creator>Flipo, Marion ; Beghyn, Terence ; Leroux, Virginie ; Florent, Isabelle ; Deprez, Benoit P ; Deprez-Poulain, Rebecca F</creator><creatorcontrib>Flipo, Marion ; Beghyn, Terence ; Leroux, Virginie ; Florent, Isabelle ; Deprez, Benoit P ; Deprez-Poulain, Rebecca F</creatorcontrib><description>Proteases that are expressed during the erythocytic stage of Plasmodium falciparum are newly explored drug targets for the treatment of malaria. We report here the discovery of potent inhibitors of PfA-M1, a metallo-aminopeptidase of the parasite. These compounds are based on a malonic hydroxamic template and present a very good selectivity toward neutral aminopeptidase (APN-CD13), a related protease in mammals. Structure−activity relationships in these series are described. Further optimization of the best inhibitor yielded a nanomolar, selective inhibitor of PfA-M1. This inhibitor displays good physicochemical and pharmacokinetic properties and a promising antimalarial activity.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm061169b</identifier><identifier>PMID: 17326615</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Aminopeptidases - antagonists &amp; inhibitors ; Aminopeptidases - chemistry ; Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials - chemical synthesis ; Antimalarials - chemistry ; Antimalarials - pharmacology ; Antiparasitic agents ; Biochemistry ; Biochemistry, Molecular Biology ; Biodiversity ; Biological and medical sciences ; Cells, Cultured ; Cellular Biology ; Erythrocytes - drug effects ; Erythrocytes - parasitology ; Humans ; Hydroxamic Acids - chemical synthesis ; Hydroxamic Acids - chemistry ; Hydroxamic Acids - pharmacology ; Life Sciences ; Malonates - chemical synthesis ; Malonates - chemistry ; Malonates - pharmacology ; Medical sciences ; Metalloproteases - antagonists &amp; inhibitors ; Metalloproteases - chemistry ; Microbiology and Parasitology ; Molecular biology ; Pharmacology. Drug treatments ; Plasmodium falciparum ; Plasmodium falciparum - drug effects ; Plasmodium falciparum - enzymology ; Protistology ; Quantitative Structure-Activity Relationship ; Solubility ; Systematics, Phylogenetics and taxonomy ; Zinc</subject><ispartof>Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1322-1334</ispartof><rights>Copyright © 2007 American Chemical Society</rights><rights>2007 INIST-CNRS</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a447t-4e42a1bee607ae7878343af95a899bf5e3ccc411c54daabf07407ed0c2fb947d3</citedby><cites>FETCH-LOGICAL-a447t-4e42a1bee607ae7878343af95a899bf5e3ccc411c54daabf07407ed0c2fb947d3</cites><orcidid>0000-0003-2863-5721 ; 0000-0002-7140-6417 ; 0000-0002-2777-4538 ; 0000-0002-3318-5297</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm061169b$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm061169b$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18652533$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17326615$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://mnhn.hal.science/mnhn-02904302$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Flipo, Marion</creatorcontrib><creatorcontrib>Beghyn, Terence</creatorcontrib><creatorcontrib>Leroux, Virginie</creatorcontrib><creatorcontrib>Florent, Isabelle</creatorcontrib><creatorcontrib>Deprez, Benoit P</creatorcontrib><creatorcontrib>Deprez-Poulain, Rebecca F</creatorcontrib><title>Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Proteases that are expressed during the erythocytic stage of Plasmodium falciparum are newly explored drug targets for the treatment of malaria. We report here the discovery of potent inhibitors of PfA-M1, a metallo-aminopeptidase of the parasite. These compounds are based on a malonic hydroxamic template and present a very good selectivity toward neutral aminopeptidase (APN-CD13), a related protease in mammals. Structure−activity relationships in these series are described. Further optimization of the best inhibitor yielded a nanomolar, selective inhibitor of PfA-M1. This inhibitor displays good physicochemical and pharmacokinetic properties and a promising antimalarial activity.</description><subject>Aminopeptidases - antagonists &amp; inhibitors</subject><subject>Aminopeptidases - chemistry</subject><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials - chemical synthesis</subject><subject>Antimalarials - chemistry</subject><subject>Antimalarials - pharmacology</subject><subject>Antiparasitic agents</subject><subject>Biochemistry</subject><subject>Biochemistry, Molecular Biology</subject><subject>Biodiversity</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Cellular Biology</subject><subject>Erythrocytes - drug effects</subject><subject>Erythrocytes - parasitology</subject><subject>Humans</subject><subject>Hydroxamic Acids - chemical synthesis</subject><subject>Hydroxamic Acids - chemistry</subject><subject>Hydroxamic Acids - pharmacology</subject><subject>Life Sciences</subject><subject>Malonates - chemical synthesis</subject><subject>Malonates - chemistry</subject><subject>Malonates - pharmacology</subject><subject>Medical sciences</subject><subject>Metalloproteases - antagonists &amp; inhibitors</subject><subject>Metalloproteases - chemistry</subject><subject>Microbiology and Parasitology</subject><subject>Molecular biology</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasmodium falciparum</subject><subject>Plasmodium falciparum - drug effects</subject><subject>Plasmodium falciparum - enzymology</subject><subject>Protistology</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Solubility</subject><subject>Systematics, Phylogenetics and taxonomy</subject><subject>Zinc</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0U2P0zAQBmALgdiycOAPIF9AAingr9jJsVoBu9CFSltA4mJNnAlxSeJipxX8e7Lbqr0gcRrZ8-jVSC8hTzl7zZngb9Y905zrsrpHZjwXLFMFU_fJjDEhMqGFPCOPUlozxiQX8iE540YKrXk-I-2nsMOO3mCHbvQ7pFdD6ys_hphoaOjYIv3uB0eXHaQ-1B46Ou_9EDa4GX0NCemymWfXnEKiyzDiMN6RafTQQbx7_Jh-02PyoIEu4ZPDPCdf3r1dXVxmi8_vry7miwyUMmOmUAngFaJmBtAUppBKQlPmUJRl1eQonXOKc5erGqBqmFHMYM2caKpSmVqek1f73BY6u4nTGfGPDeDt5Xxh-6EdLBMlU5KJHZ_wiz3exPBri2m0vU8Ouw4GDNtkDRNaCqH-C3lpcq30beLLPXQxpBSxOd7Amb0tyx7LmuyzQ-i26rE-yUM7E3h-AJAcdE2Ewfl0coXORS7l5LK982nE38c9xJ9WG2lyu1re2G_Xiw9fi9VHy0-54JJdh20cpkb-ceBfKl22jg</recordid><startdate>20070322</startdate><enddate>20070322</enddate><creator>Flipo, Marion</creator><creator>Beghyn, Terence</creator><creator>Leroux, Virginie</creator><creator>Florent, Isabelle</creator><creator>Deprez, Benoit P</creator><creator>Deprez-Poulain, Rebecca F</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-2863-5721</orcidid><orcidid>https://orcid.org/0000-0002-7140-6417</orcidid><orcidid>https://orcid.org/0000-0002-2777-4538</orcidid><orcidid>https://orcid.org/0000-0002-3318-5297</orcidid></search><sort><creationdate>20070322</creationdate><title>Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents</title><author>Flipo, Marion ; Beghyn, Terence ; Leroux, Virginie ; Florent, Isabelle ; Deprez, Benoit P ; Deprez-Poulain, Rebecca F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a447t-4e42a1bee607ae7878343af95a899bf5e3ccc411c54daabf07407ed0c2fb947d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aminopeptidases - antagonists &amp; inhibitors</topic><topic>Aminopeptidases - chemistry</topic><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials - chemical synthesis</topic><topic>Antimalarials - chemistry</topic><topic>Antimalarials - pharmacology</topic><topic>Antiparasitic agents</topic><topic>Biochemistry</topic><topic>Biochemistry, Molecular Biology</topic><topic>Biodiversity</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Cellular Biology</topic><topic>Erythrocytes - drug effects</topic><topic>Erythrocytes - parasitology</topic><topic>Humans</topic><topic>Hydroxamic Acids - chemical synthesis</topic><topic>Hydroxamic Acids - chemistry</topic><topic>Hydroxamic Acids - pharmacology</topic><topic>Life Sciences</topic><topic>Malonates - chemical synthesis</topic><topic>Malonates - chemistry</topic><topic>Malonates - pharmacology</topic><topic>Medical sciences</topic><topic>Metalloproteases - antagonists &amp; inhibitors</topic><topic>Metalloproteases - chemistry</topic><topic>Microbiology and Parasitology</topic><topic>Molecular biology</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasmodium falciparum</topic><topic>Plasmodium falciparum - drug effects</topic><topic>Plasmodium falciparum - enzymology</topic><topic>Protistology</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Solubility</topic><topic>Systematics, Phylogenetics and taxonomy</topic><topic>Zinc</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flipo, Marion</creatorcontrib><creatorcontrib>Beghyn, Terence</creatorcontrib><creatorcontrib>Leroux, Virginie</creatorcontrib><creatorcontrib>Florent, Isabelle</creatorcontrib><creatorcontrib>Deprez, Benoit P</creatorcontrib><creatorcontrib>Deprez-Poulain, Rebecca F</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flipo, Marion</au><au>Beghyn, Terence</au><au>Leroux, Virginie</au><au>Florent, Isabelle</au><au>Deprez, Benoit P</au><au>Deprez-Poulain, Rebecca F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2007-03-22</date><risdate>2007</risdate><volume>50</volume><issue>6</issue><spage>1322</spage><epage>1334</epage><pages>1322-1334</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Proteases that are expressed during the erythocytic stage of Plasmodium falciparum are newly explored drug targets for the treatment of malaria. We report here the discovery of potent inhibitors of PfA-M1, a metallo-aminopeptidase of the parasite. These compounds are based on a malonic hydroxamic template and present a very good selectivity toward neutral aminopeptidase (APN-CD13), a related protease in mammals. Structure−activity relationships in these series are described. Further optimization of the best inhibitor yielded a nanomolar, selective inhibitor of PfA-M1. This inhibitor displays good physicochemical and pharmacokinetic properties and a promising antimalarial activity.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>17326615</pmid><doi>10.1021/jm061169b</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-2863-5721</orcidid><orcidid>https://orcid.org/0000-0002-7140-6417</orcidid><orcidid>https://orcid.org/0000-0002-2777-4538</orcidid><orcidid>https://orcid.org/0000-0002-3318-5297</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1322-1334
issn 0022-2623
1520-4804
language eng
recordid cdi_hal_primary_oai_HAL_mnhn_02904302v1
source ACS Publications; MEDLINE
subjects Aminopeptidases - antagonists & inhibitors
Aminopeptidases - chemistry
Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimalarials - chemical synthesis
Antimalarials - chemistry
Antimalarials - pharmacology
Antiparasitic agents
Biochemistry
Biochemistry, Molecular Biology
Biodiversity
Biological and medical sciences
Cells, Cultured
Cellular Biology
Erythrocytes - drug effects
Erythrocytes - parasitology
Humans
Hydroxamic Acids - chemical synthesis
Hydroxamic Acids - chemistry
Hydroxamic Acids - pharmacology
Life Sciences
Malonates - chemical synthesis
Malonates - chemistry
Malonates - pharmacology
Medical sciences
Metalloproteases - antagonists & inhibitors
Metalloproteases - chemistry
Microbiology and Parasitology
Molecular biology
Pharmacology. Drug treatments
Plasmodium falciparum
Plasmodium falciparum - drug effects
Plasmodium falciparum - enzymology
Protistology
Quantitative Structure-Activity Relationship
Solubility
Systematics, Phylogenetics and taxonomy
Zinc
title Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A39%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Selective%20Inhibitors%20of%20the%20Zinc%20Plasmodial%20Aminopeptidase%20PfA-M1%20as%20Potential%20Antimalarial%20Agents&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Flipo,%20Marion&rft.date=2007-03-22&rft.volume=50&rft.issue=6&rft.spage=1322&rft.epage=1334&rft.pages=1322-1334&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm061169b&rft_dat=%3Cproquest_hal_p%3E19756461%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19756461&rft_id=info:pmid/17326615&rfr_iscdi=true